Blog
NETRF Research Symposium
Latest in NET Cancer Research Neuroendocrine Tumor Research Foundation (NETRF) held its 11th Annual Research Symposium on May 2-3, 2019, in Cambridge, MA. More than
May 15, 2019
No Comments
Category: For Researchers
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Blog
2019 NET Research Grants
NETRF Announces 2019 Neuroendocrine Cancer Research Funding Opportunities New award to fund early career investigators The Neuroendocrine Tumor Research Foundation (NETRF) has announced a new
May 15, 2019
No Comments
Blog
Developing a NET Cell Line
NETRF & Broad Institute Work to Fill Research Void The lack of publicly available, reliable NET cell lines is a barrier in neuroendocrine tumor research,
May 15, 2019
1 Comment
Blog
Exploring Targeted Alpha Therapy for Neuroendocrine Tumors
Increasing Precision in Cancer Cell Death to Prevent Metastasis In housework and lawn work, it is important to have the right tool for the job.
April 16, 2019
No Comments
Blog
New Mentored Award to Help Launch NET Careers
The Neuroendocrine Tumor Research Foundation (NETRF) announces a new NETRF Mentored Award for early career researchers, supported by Ipsen. The two-year grant for those in
April 11, 2019
No Comments
Blog
NETRF’s Pursuit of NET Organoids Recognized at International Meeting
A NETRF-funded study on the development of neuroendocrine tumor organoids won the best scientific poster award at the 2019 annual meeting of the European Neuroendocrine
March 18, 2019
1 Comment
Blog
NETRF Announces $2.5 Million in Research to Advance the NETs
New grants to explore CAR-T, PRRT, a vaccine for NETs and other innovative approaches.
February 1, 2019
No Comments
Blog
NETRF Researchers Named as World’s Most Influential Scientists for 2018
Clarivate Analytics has released the most influential researcher list for 2018, which identifies exceptional researchers whose highly cited work is among the top 1% in their field around the world.
November 29, 2018
No Comments
Blog
Tb-161: Novel Radionuclide to be Tested
Early Research on Targeting Single Cancer Cells to Prevent Metastasis Despite the effectiveness of Peptide Receptor Radionuclide Therapy (PRRT) to prolong survival of those with
October 16, 2018
3 Comments
Blog
New Grant Explores Novel Drug Delivery System
Antibody-drug conjugate aims to combine the benefits of targeted therapy and chemotherapy Renata Jaskula-Sztul, PhD, Assistant Professor of Surgical Oncology at the University of Alabama
October 15, 2018
2 Comments